ACCOMPLISH Trademark

Trademark Overview

On Thursday, January 30, 2020, a trademark application was filed for ACCOMPLISH with the United States Patent and Trademark Office. The USPTO has given the ACCOMPLISH trademark a serial number of 88778614. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 28, 2023. This trademark is owned by Cingulate Therapeutics LLC. The ACCOMPLISH trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

conducting clinical trials for others in the field of pharmaceuticals for the treatment of attention deficit hyperactivity disorder (ADHD)
accomplish

General Information

Serial Number88778614
Word MarkACCOMPLISH
Filing DateThursday, January 30, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 28, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 2, 2020

Trademark Statements

Goods and Servicesconducting clinical trials for others in the field of pharmaceuticals for the treatment of attention deficit hyperactivity disorder (ADHD)

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 4, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCingulate Therapeutics LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressKansas City, KS 66205
Party NameCingulate Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressKansas City, KS 66205

Trademark Events

Event DateEvent Description
Monday, August 28, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 28, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, February 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 9, 2023SOU EXTENSION 5 GRANTED
Tuesday, January 24, 2023SOU EXTENSION 5 FILED
Thursday, February 9, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 24, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, January 17, 2023ASSIGNED TO EXAMINER
Tuesday, July 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 15, 2022SOU EXTENSION 4 GRANTED
Friday, July 15, 2022SOU EXTENSION 4 FILED
Friday, July 15, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, January 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 21, 2022SOU EXTENSION 3 GRANTED
Friday, January 21, 2022SOU EXTENSION 3 FILED
Friday, January 21, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, July 28, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 26, 2021SOU EXTENSION 2 GRANTED
Monday, July 26, 2021SOU EXTENSION 2 FILED
Monday, July 26, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, July 20, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 20, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 20, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 22, 2021SOU EXTENSION 1 GRANTED
Friday, January 22, 2021SOU EXTENSION 1 FILED
Friday, January 22, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, July 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 2, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 2, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 13, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 28, 2020ASSIGNED TO LIE
Tuesday, April 21, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 21, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, April 21, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, April 21, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, April 21, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, April 20, 2020ASSIGNED TO EXAMINER
Tuesday, February 4, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 3, 2020NEW APPLICATION ENTERED

Related Keywords

accomplish deficit attention hyperactivity disorder adhd treatment pharmaceuticals clinical trials others